Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

September 19, 2017

Study Completion Date

May 22, 2018

Conditions
SclerodermaSystemic SclerosisRaynaud PhenomenaRaynaud's Disease
Interventions
DEVICE

Celution Device

ADRCs prepared using the investigational Celution Device

OTHER

Placebo

Placebo

Trial Locations (19)

10021

Hospital for Special Surgery, New York

15261

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

20007

Georgetown University Hospital, Washington D.C.

21224

Johns Hopkins University, Baltimore

27710

Duke University Medical Center, Durham

40509

Central Kentucky Research Associates, Inc., Lexington

44195

Cleveland Clinic, Cleveland

49546

West Michigan Rheumatology, PLLC, Grand Rapids

60611

Northwestern University, Chicago

64114

Center For Pharmaceutical Research, Kansas City

67207

Heartland Research Associates, Wichita

72205

Baptist Health Center for Clinical Research, Little Rock

77030

University of Texas Houston Medical School, Houston

85253

Arizona Arthritis and Rheumatology Research, PLLC, Phoenix

90045

Arthritis Associates of Southern California, Los Angeles

90095

UCLA David Geffen School of Medicine, Los Angeles

02118

Boston University Medical Center, Boston

08901

Robert Wood Johnson Medical School, New Brunswick

Sponsors
All Listed Sponsors
lead

Cytori Therapeutics

INDUSTRY